Oncocyte
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Oncocyte and buy or sell other stocks, ETFs, and their options commission-free!About OCX
Insight Molecular Diagnostics, Inc. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO.
CEOJoshua Riggs
CEOJoshua Riggs
Employees49
Employees49
HeadquartersNashville, Tennessee
HeadquartersNashville, Tennessee
Founded2009
Founded2009
Employees49
Employees49
OCX Key Statistics
Market cap83.30M
Market cap83.30M
Price-Earnings ratio-1.84
Price-Earnings ratio-1.84
Dividend yield—
Dividend yield—
Average volume28.30K
Average volume28.30K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$8.51
52 Week high$8.51
52 Week low$1.92
52 Week low$1.92
Stock Snapshot
The current Oncocyte(OCX) stock price is $2.91, with a market capitalization of 83.3M. The stock trades at a price-to-earnings (P/E) ratio of -1.84.
During the trading day, Oncocyte(OCX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Oncocyte(OCX) stock has reached 0, versus its average volume of 28.3K.
The stock's 52-week range extends from a low of $1.92 to a high of $8.51.
The stock's 52-week range extends from a low of $1.92 to a high of $8.51.
People also own
Based on the portfolios of people who own OCX. This list is generated using Robinhood data, and it’s not a recommendation.